Article: Tularik and Japan Tobacco Announce Major Drug Discovery Alliance.

Tularik to Form a New Subsidiary Dedicated to the Discovery of Novel

Therapeutics for the Treatment of Metabolic Diseases

SOUTH SAN FRANCISCO, Calif., May 31 /PRNewswire/ --

Tularik Inc. (Nasdaq: TLRK) and Japan Tobacco Inc. announced today that they have entered into a broad collaborative agreement for the discovery, development and commercialization of products for the treatment of metabolic diseases. Under the terms of the agreement, Tularik will form a wholly-owned subsidiary to conduct the research portion of the collaboration. The research to be conducted by the subsidiary will be independent from any research programs that currently ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!